Back to discover
Drug

Sulfur

In clinical development
Emerging researchLate-stage development
Also known as Acnomel, Acnotex, Ala Seb, Ala Seb T+46 more

Acnomel, Acnotex, Ala Seb, Ala Seb T, Avar, BP 10-Wash, BP Cleansing Wash, Bensulfoid, Brimstone, Clenia, End-Zit, Fostex Bar, Fostril, Liquimat, Meted, Nicosyn, Novacet, NuOx, Pazol XS, Pernox Scrub Cleanser, Plexion, Prascion, Rezamid, Rosac, Rosanil, Rosula, Rosula AQ, Rosula AQ Cleanser, Sastid Soap, Sebex, Sebulex, Sebutone, SulZee Wash, Sulfacet-R, Sulfatol, Sulfatol Cleanser, Sulfo-Lo, Sulfoam, Sulforcin, Sulmasque, Sulpho-Lac, Sumadan Wash, Sumadan XLT, Sumaxin, Suphera, Thylox, Topisulf, Zencia Wash, Zetacet, Sulphur.

1
Research papers
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Comparing Sulfur to Different Regimes of Permethrin for the Treatment of Scabies

Clinical trial2022-11-12Completed · ClinicalTrials.gov

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Sulfur
Aliases & brands
AcnomelAcnotexAla SebAla Seb TAvarBP 10-WashBP Cleansing WashBensulfoidBrimstoneCleniaEnd-ZitFostex BarFostrilLiquimatMetedNicosynNovacetNuOxPazol XSPernox Scrub CleanserPlexionPrascionRezamidRosacRosanilRosulaRosula AQRosula AQ CleanserSastid SoapSebexSebulexSebutoneSulZee WashSulfacet-RSulfatolSulfatol CleanserSulfo-LoSulfoamSulforcinSulmasqueSulpho-LacSumadan WashSumadan XLTSumaxinSupheraThyloxTopisulfZencia WashZetacetSulphur
RxNorm CUI
10223
ChEMBL ID
CHEMBL1235452
ATC codes
D10AB02D11AC08
UNII
70FD1KFU70

Clinical trials

2 trials

The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.

Development programme
CLINICALTRIALS.GOV · LIVE REGISTRY
2
registered trials across all phases
LATEST COMPLETION 2022
1
Late-stage (III+)
2
Completed
PHASE DISTRIBUTIONn = 2
Phase 11Phase 31

Late-stage studies

Phase III+ trials still open or recently active — where late-stage evidence is being generated.

Recent completions

Trials that read out recently, adding to the completed evidence base.

Research activity

1 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Major research themes3
Gastrointestinal Microbiome1Hydrogen Sulfide1Neoplasms1
Journals, researchers & institutions
Top journals
  • Nature metabolism1
Leading researchers
  • Anantharaman K1
  • Andrea Azcarate-Peril M1
  • Arbeev KG1
  • Garcia-Peterson LM1
  • Hsiao YC1
  • Ji M1
  • Li JL1
  • Li X1
Leading institutions
free-text, unnormalised
  • Department of Microbiology and Immunology and Lineberger Comprehensive Cancer Center1
  • Duke University School of Medicine1
  • Epigenetics and Stem Cell Biology Laboratory1
  • Gillings School of Global Public Health1
  • National Institute of Environmental Health Sciences1
  • Signal Transduction Laboratory1

Related drugs

1 matches

Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).

Studied across the same disease area as Sulfur in the shared literature.

1 shared disease1 shared paper
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
  • Europe PMC — research literature
  • ClinicalTrials.gov — clinical trials